Inflammation is a balanced physiological response – the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and chronic diseases. To help keep tabs on inflammation, immune cells employ a molecular machine called the NLRP3 inflammasome. NLRP3 is inactive in a healthy cell, but is switched “on” when the cell’s mitochondria (energy-generating organelles) are damaged by stress or exposure to bacterial toxins.
However, when the NLRP3 inflammasome gets stuck in the “on” position, it can contribute to a number of chronic inflammatory conditions, including gout, osteoarthritis, fatty liver disease and Alzheimer’s and Parkinson’s diseases. In a new mouse study, researchers at University of California San Diego School of Medicine discovered a unique approach that might help treat some chronic inflammatory diseases: force cells to eliminate damaged mitochondria before they activate the NLRP3 inflammasome.
The study, published April 11, 2019 by Cell Metabolism, was led by senior author Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology and Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases at UC San Diego School of Medicine, and first author Elsa Sanchez-Lopez, PhD, a senior postdoctoral researcher in Karin’s lab.
In a 2018 study published in Nature, Karin’s team had shown that damaged mitochondria activate the NLRP3 inflammasome. The researchers also found that the NLRP3 inflammasome is de-activated when mitochondria are removed by the cell’s internal waste recycling process, called mitophagy.
“After that, we wondered if we could reduce harmful excess inflammation by intentionally inducing mitophagy, which would eliminate damaged mitochondria and should in turn pre-emptively inhibit NLRP3 inflammasome activation,” Karin said. “But at the time we didn’t have a good way to induce mitophagy.”
More recently, Sanchez-Lopez was studying how macrophages regulate their uptake of choline, a nutrient critical for metabolism, when she discovered something that can initiate mitophagy: an inhibitor of the enzyme choline kinase (ChoK). With ChoK inhibited, choline is no longer incorporated into mitochondrial membranes. As a result, the cells perceive the mitochondria as damaged, and cleared them away by mitophagy.
“Most importantly, by getting rid of damaged mitochondria with ChoK inhibitors, we were finally able to inhibit NLRP3 inflammasome activation,” Karin said.
To test their new ability to control NLRP3 inflammasome in a living system, the researchers turned to mice. They discovered that treatment with ChoK inhibitors prevented acute inflammation caused by uric acid (accumulation of which triggers gout flares) and a bacterial toxin.
By several measures, ChoK inhibitor treatment also reversed chronic inflammation associated with a genetic disease called Muckle-Well Syndrome, which is caused by mutations in NLRP3 genes. One such measure is spleen size – the larger the spleen, the more inflammation. The spleens of Muckle-Well Syndrome mice are on average twice as large as normal mice, but their spleen sizes normalized after ChoK inhibitor treatment.
NLRP3 inflammasome promotes inflammation because it triggers the release of two very potent pro-inflammatory molecules called cytokines: interleukin (IL)-1? and IL-18. According to Karin, there are existing drugs that can block IL-1?, but not IL-18. ChoK inhibitors, his team found, can reduce both cytokines.
“There are several diseases, including lupus and osteoarthritis, whose treatment will likely require dual inhibition of both IL-1? and IL-18,” Karin said.
The Latest on: Chronic inflammatory disease
via Google News
The Latest on: Chronic inflammatory disease
- What It’s Like Being Pregnant When You Have Crohn’s Diseaseon July 2, 2021 at 9:01 am
For so many years, my body had only let me down. Now, here it was, doing exactly the thing I wanted so badly, this beautiful miracle. I was so thankful for it.” ...
- 5 Pro Athletes Battling Crohn’s Diseaseon July 1, 2021 at 1:00 pm
Crohn’s Disease doesn’t play favorites. Anyone can be diagnosed with the often-debilitating inflammatory bowel disease, which causes chronic inflammation of the GI tract. The disease is marked by ...
- How 3 Men Cope With the Stress and Anxiety of Living With a Chronic Conditionon July 1, 2021 at 10:06 am
When you have a chronic condition, there’s the obvious physical toll, but there’s an equally daunting psychological one. What’s the secret to dealing with the impact on your mental health? Three men ...
- Mesoblast Provides Update on Program for Chronic Low Back Pain Due to Degenerative Disc Diseaseon June 30, 2021 at 4:48 pm
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the strategy for bringing rexlemestrocel-L to patients ...
- PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Diseaseon June 30, 2021 at 4:00 am
PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that ...
- Inflammatory skin diseases linked to chronic kidney disease: Studyon June 29, 2021 at 8:45 pm
Researchers from a recent study have found out that inflammatory skin diseases like atopic eczema, psoriasis and hidradenitis suppurativa are weakly associated with chronic kidney disease ...
- Eating This Type of Diet Can Reduce Chronic Pain and Inflammation—and You Don't Have to Give Up Pasta or Wineon June 29, 2021 at 2:19 pm
It's the longer-lasting inflammation that happens near our organs that can do a number on our longevity and overall well-being.) One of the most recent discoveries related to inflammation—and ...
- COVID-19 Vaccine: Should I Get It If I Have Crohn's Disease?on June 28, 2021 at 5:52 am
People with Crohn's disease often need immunosuppresive medications to manage the condition. However, this has raised concerns about COVID-19 infection and vaccination. Learn more.
- Latest News in Parkinson Disease: Chronic Gut Inflammation, Defining Advanced Disease, and Moreon June 25, 2021 at 1:00 pm
An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™. An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences ™. As reported ...
- Dissecting Inflammation to Understand Chronic Disease in Type 2 Diabeteson June 24, 2021 at 10:47 am
Type 2 diabetes (T2D) is a chronic inflammatory disease affecting approximately 415 million people worldwide, and its prevalence is rising in adults, increasing the risk of developing co-morbidities ...
via Bing News